NCT01035528 - Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2010

Conditions

Coronary Artery DiseaseType 2 Diabetes

Interventions

DRUG

insulin glargine

antidiabetic treatment with insulin glargine sc o.d. titrated to the target fasting glucose type 2 diabetes ≤110 mg/dl

DRUG

metformin

use of oral metformin o.d or b.d titrated up to 2000 mg daily for to the target fasting glucose ≤110 mg/dl

Trial Locations (1)

Staedt. Klinikum Muenchen Bogenhausen, Munich